Mazor Robotics (NASDAQ: MZOR) and Koninklijke Philips (NYSE:PHG) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.
Koninklijke Philips pays an annual dividend of $0.73 per share and has a dividend yield of 1.8%. Mazor Robotics does not pay a dividend. Koninklijke Philips pays out 43.5% of its earnings in the form of a dividend. Koninklijke Philips has raised its dividend for 5 consecutive years.
This is a breakdown of recent recommendations and price targets for Mazor Robotics and Koninklijke Philips, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Mazor Robotics currently has a consensus price target of $40.00, indicating a potential downside of 34.00%. Koninklijke Philips has a consensus price target of $37.00, indicating a potential downside of 8.96%. Given Koninklijke Philips’ stronger consensus rating and higher probable upside, analysts clearly believe Koninklijke Philips is more favorable than Mazor Robotics.
Volatility and Risk
Mazor Robotics has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500.
This table compares Mazor Robotics and Koninklijke Philips’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Mazor Robotics and Koninklijke Philips’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Mazor Robotics||$36.38 million||42.52||-$18.66 million||($0.70)||-86.59|
|Koninklijke Philips||$27.13 billion||1.40||$1.60 billion||$1.68||24.19|
Koninklijke Philips has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
26.4% of Mazor Robotics shares are held by institutional investors. Comparatively, 7.2% of Koninklijke Philips shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Koninklijke Philips beats Mazor Robotics on 13 of the 16 factors compared between the two stocks.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.
About Koninklijke Philips
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.